The management of osteoarthritis symptomatology through nanotechnology: a patent review-Reference-Cited by-同舟云学术

The management of osteoarthritis symptomatology through nanotechnology: a patent review

Published:2023-09-21 Issue:7 Volume:40 Page:475-490
ISSN:0265-2048
Container-title:Journal of Microencapsulation
language:en
Short-container-title:Journal of Microencapsulation

Author:

Santos Mariana Mendonça¹,Santos Anamaria Mendonça¹,Nascimento Júnior José Adão Carvalho²,Andrade Tatianny De Araujo³,Rajkumar Gomathi⁴,Frank Luiza Abrahão⁵,Serafini Mairim Russo¹²

Affiliation:

1. Postgraduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Brazil

2. Postgraduate Program in Pharmaceutical Sciences, Federal University of Sergipe, São Cristóvão, Brazil

3. Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Sergipe, Brazil

4. Department of Botany, Sri Sarada College for Women (Autonomous), Affiliated to Periyar University, Salem, India

5. Postgraduate Program in Pharmaceutical Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Informa UK Limited

Subject

Colloid and Surface Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Pharmaceutical Science,Bioengineering

Link

https://www.tandfonline.com/doi/pdf/10.1080/02652048.2023.2258955

Reference84 articles.

1. Osteoarthritis

2. Drug delivery in degenerative joint disease: Where we are and where to go?☆

3. Advances in Oral Drug Delivery

4. Intra-Articular Drug Delivery: A Fast Growing Approach

5. Oxidative stress and inflammation in osteoarthritis pathogenesis: Role of polyphenols

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Technological trends in cyclodextrin inclusion complexes for improving cardiovascular drug therapy: A patent review;Journal of Drug Delivery Science and Technology;2024-11

2. Diabetes and Osteoarthritis: Exploring the Interactions and Therapeutic Implications of Insulin, Metformin, and GLP-1-Based Interventions;Biomedicines;2024-07-23